Trulieve Cannabis is trading 5.39% lower at $10.97 as U.S. markets sell off sharply. - Reuters reported broad risk-off trading as investors reassessed AI and data-center risks after the midterm results; this is market context, not a reported company-specific catalyst. - The November 5 earnings were positive on revenue and margin measures, but available reporting does not establish they caused the share move. - Supplied price context shows the decline from the prior close; current volume data was not provided.